EUVIMEDEUVIMED entdecken
Kommentar

Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease

Mandy E Turner, Elena Aikawa

Kidney International · 2026-09 · 110 (3) · 529-532

DOI: 10.1016/j.kint.2026.06.018 ↗

Kurz gefasst

Kommentar in der Zeitschrift Kidney International, 2026-09. Verfasst von Mandy E Turner und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interdisciplinary Cardiovascular Sciences, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachus…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Vascular Calcification. Die Arbeit nennt 9 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institutes of Health, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite decades of investigation, effective therapies for medial arterial calcification in chronic kidney disease remain lacking. Emerging therapeutic targets increasingly extend beyond systemic drivers of calcification and now seek to address direct vascular cellular mechanisms and the calcium-phosphate mineralization itself. In this issue, Öztürk et al. describe platelet-derived growth factor receptor β activation as a potent mediator of chronic kidney disease-induced vascular smooth muscle cell osteogenic differentiation and calcification, supporting vascular cell targeting as an emerging therapeutic axis in chronic kidney disease-associated medial arterial calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicVascular CalcificationHumansAnimalsReceptor, Platelet-Derived Growth Factor betaMuscle, Smooth, VascularCell DifferentiationOsteogenesisSignal Transduction

Substanzen

Receptor, Platelet-Derived Growth Factor beta

Autor:innen und Institutionen

  • Center for Interdisciplinary Cardiovascular Sciences, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: mturner14@bwh.harvard.edu.
  • Center for Interdisciplinary Cardiovascular Sciences, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Center for Excellence in Vascular Biology, Department of Me…

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • American Heart Association
  • Pfizer
  • Public Risk Management Association

Zitieren

APA

Turner, M. E., & Aikawa, E. (2026). Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease. Kidney International, 110(3), 529-532. https://doi.org/10.1016/j.kint.2026.06.018

Vancouver

Turner ME, Aikawa E. Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease. Kidney International. 2026;110(3):529-532. doi:10.1016/j.kint.2026.06.018

BibTeX
@article{Turner2026,
  author = {Turner, Mandy E and Aikawa, Elena},
  title = {Toward multilevel therapeutic targeting of medial arterial calcification in chronic kidney disease},
  journal = {Kidney International},
  year = {2026},
  volume = {110},
  number = {3},
  pages = {529--532},
  doi = {10.1016/j.kint.2026.06.018}
}
Kostenlos starten →